Table 2.
Groups | n | LATS2 expression | P | |
---|---|---|---|---|
High | Low | |||
Gender | 0.165 | |||
Male | 267 | 86 | 181 | |
Female | 90 | 22 | 68 | |
Age (year) | 0.797 | |||
≥ 60 | 202 | 60 | 142 | |
< 60 | 155 | 48 | 107 | |
Tumor size | 0.572 | |||
≥ 5 | 252 | 74 | 178 | |
< 5 | 105 | 34 | 71 | |
Borrmann’s types | 0.975 | |||
Bor.I + II | 30 | 9 | 21 | |
Bor.III + IV | 327 | 99 | 228 | |
WHO’s histological types | 0.424 | |||
Papillary adenocarcinoma | 6 | 3 | 3 | |
Tubular adenocarcinoma | ||||
Well differentiated | 10 | 5 | 5 | |
Moderately differentiated | 80 | 23 | 57 | |
Poorly differentiated | 219 | 68 | 151 | |
Signet ring cell adenocarcinoma | 27 | 6 | 21 | |
Mucinous adenocarcinoma | 15 | 3 | 12 | |
Lauren’s types | 0.211 | |||
Intestinal | 96 | 25 | 71 | |
Diffuse | 180 | 60 | 120 | |
Mixed | 81 | 23 | 58 | |
Depth of invasion | 0.615 | |||
T1 + 2 | 26 | 9 | 17 | |
T3 + 4 | 331 | 99 | 232 | |
Lymph node metastasis | 0.503 | |||
N0 | 78 | 26 | 52 | |
N1–3 | 279 | 82 | 197 | |
Distant metastasis | 0.130 | |||
M0 | 345 | 102 | 243 | |
M1 | 12 | 6 | 6 | |
TNM staging | 0.047 | |||
I + II | 100 | 38 | 62 | |
III + IV | 257 | 70 | 187 |
Significance of P < 0.05 is indicated in italic